Treatment of glaucoma continues to be directed at lowering intraocular pressure to decrease
the likelihood of disease progression. In the future intraocular pressure reduction might be …

OBJECTIVES: The Early Manifest Glaucoma Trial (EMGT) will evaluate the effectiveness of
reducing intraocular pressure (IOP) in early, previously untreated open-angle glaucoma. Its …

Ophthalmologists have had difficulty with managing patients who had all the hallmarks of
chronic open-angle glaucoma but whose intraocular pressure (IOP) readings were …

Objectives To determine the morphometric parameters in high-tension glaucoma (HTG) and
normal-tension glaucoma (NTG) with a confocal scanning laser ophthalmoscope, and to …

A LARGE BODY OF EVIDENCE SUGGESTS THAT INTRAOCU-lar pressure (IOP) is a
critical factor in most patients with glaucomatous optic nerve damage, whether their baseline …

FOR 2DECADES, LASERS have played an impor-tant role in the management of patients
with glaucoma. However, the roles of laser trabeculoplasty and laser cycloablation have …

Glaucoma is a prevalent cause of visual impairment and blindness in the world. It is actually
a heterogeneous group of optic neuropathies that have characteristic clinical features. Most …

Is the IOP the main problem in roughly 90% of primary open-angle glaucomas? This is
related to the following frequently asked question: Is IOP the cause, the effect or a sign of …

WE KNOW that glaucoma, a slowly progressive optic neuropathy, 1 causes irreversible loss
of vision. It is a major cause of blindness in the United States and worldwide. Some patients …

Patients with chronic glaucoma are being referred at lower intraocular pressures (IOPs) than
was the case in the 1980s, 1 probably as a result of an enhanced awareness among …